What is Akumin Inc. (AKU)?

Akumin Inc. (AKU) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of AKU?

The current price of AKU is $0.29. Prices are updated in real time on Stocks360.

What is AKU's price-to-earnings (PE) ratio?

AKU's trailing twelve-month PE ratio is -0.17, based on current price and earnings per share data available on Stocks360.

What is AKU's market capitalization?

AKU's market capitalization is $26,271,266.00, placing it in the small-cap tier.

Akumin Inc. (AKU)

Stock analysis · NASDAQ · Healthcare · Medical - Diagnostics & Research

$0.29

Market Cap

$26.27M

PE (TTM)

-0.17

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.45

Day Range

$0.28 – $0.35

52-wk Range

$0.12 – $1.90

Avg Volume

N/A

Volume

7.89M

Akumin Inc. (AKU) is a publicly traded company in the Healthcare sector. Latest price: $0.29. Market cap $26.27M. Trailing PE -0.17. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Aug 12, 2020

EPS $0.04 vs est. $0.15

Missed by $0.11

Proprietary Signals

Signal snapshot temporarily unavailable.

About Akumin Inc.

Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States. Its operations are divided into two main divisions: Radiology and Oncology. Through a network of roughly 200 imaging centers, which it either owns or manages, Akumin delivers a wide array of medical imaging modalities. These include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and various other diagnostic or interventional radiology procedures. The company extends its outpatient radiology and oncology services and comprehensive solutions to approximately 1,000 hospitals and healthcare systems spanning 46 states. Established in 2015, Akumin Inc. maintains its corporate headquarters in Plantation, Florida.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.17×
P/S (TTM)	0.04×
P/B	-0.54×
PEG	0.00×
P/FCF (TTM)	1.27×
EV / EBITDA	10.34×
EV / Sales	1.93×
Earnings Yield	-586.93%
Free Cash Flow Yield	78.43%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.45B
Revenue (TTM)	$749.63M
Net Income (TTM)	-$154.19M
Free Cash Flow (TTM)	$145.55M
Net Debt	$1.42B
Working Capital	$23.43M
Gross Margin	18.84%
Operating Margin	5.56%
Net Margin	-20.22%
Return on Equity	-531.99%
Return on Invested Capital	2.54%